Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Ronak Savla

Ronak Savla

“How many people can truly say that they are working on what they dreamed of as kids? I guess I’m one of the lucky ones.” After learning about the field of nanotechnology as a high school student, Ronak saw the opportunity of combining his interest in science with his passion to help others. Ronak started working in a nanotechnology drug delivery lab during the summer after his freshman year at Rutgers University. He continued developing innovative nanoparticle drug delivery solutions during pharmacy school and graduate school. This has launched him to his current position as the Applied Drug Delivery Fellows at Catalent Pharma Solutions as part of the Rutgers Pharmaceutical Industry Fellowship Program.

  • Contributions
Sponsored

Taking a Byte out of Formulation Development

February 11, 2019

With so much technology at our disposal, it’s time to get smart in formulation by adopting in silico approaches.

0 min read

Taking a Byte out of Formulation Development

Nanotechnology Versus Cancer

March 10, 2015

With only one approved drug and many failures, the cancer vaccine field has lost some of its shine. Could nanotechnology brighten its prospects?

1 min read

Nanotechnology Versus Cancer

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.